Ibrutinib (Imbruvica): The First-In-Class Btk Inhibitor For Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, And Waldenstrom'S MacroglobulinemiaHui Liu,Zhengying PanINNOVATIVE DRUG SYNTHESIS（2016）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
